McCarthy Tétrault is delighted to announce that Euromoney Legal Media Group's Benchmark Canada named partners Andrew Reddon and Steven Mason as Canada's Intellectual Property Litigators of the Year - Patents. The award is in recognition of Mr. Reddon and Mr. Mason's exceptional knowledge of patents and superior trial skills. The pair's recent successes include their representation of AbbVie in its patent infringement case against Janssen related to AbbVie's Canadian patent on anti-IL-12 antibodies. This was Canada's first antibody engineering trial, and the action was the first in Canada dealing with the scope of protection for the new class of drugs known as "biologics". Mr. Reddon and Mr. Mason also recently successfully assisted Merck in recovering more than C$180 million in damages and interest for Apotex's infringement of Merck's Canadian lovastatin patent - possibly the largest patent...
Mccarthy Tétrault Receives Four Benchmark Canada Awards
|Profession:||McCarthy Tétrault LLP|
To continue readingFREE SIGN UP